Watch: Big Week For Drug Pricing Debate Featured On C-SPAN
KHN correspondent Emmarie Huetteman appeared on the C-SPAN program âWashington Journal,â where she fielded viewersâ calls about high drug prices and industry criticism.
Drugs
841-860 of 1,318 results
-
-
Americans Ready To Crack Down On Drug Prices That Force Some To Skip Doses
In a new poll, consumers give thumbs up to ads that display drug prices and the removal of barriers to generics, among other cost-cutting measures.
By Jay Hancock -
Podcast: KHNâs âWhat The Health?â âMedicare-For-Allâ Debate: Whoâs Going To Pay
Margot Sanger-Katz of The New York Times, Paige Winfield Cunningham of The Washington Post and Jennifer Haberkorn of the Los Angeles Times join KHNâs Julie Rovner to discuss the new âMedicare-for-allâ bill introduced by House Democrats, the grilling of pharmaceutical company CEOs by a Senate committee and new Trump administration rules that take aim at Planned Parenthood. Plus, Rovner interviews KHNâs Julie Appleby about the latest âBill of the Monthâ installment.
-
Pharma Execs Dig In For A Fight Against Outraged Senators
The Senate Finance Committee grilled executives from seven major drugmakers on Tuesday.
By Emmarie Huetteman and Jay Hancock -
Congress Squares Off With Pharma CEOs In Showdown Over High Drug Prices
Tuesdayâs Senate Finance Committee hearing could produce fireworks over prices, R&D costs and executive compensation.
By Emmarie Huetteman and Jay Hancock -
In Florida, Drug Importation From Canada Finds New Champions, Old Snags
The stateâs governor said the plan has the full support of the White House. But the Trump administration was noncommittal about whether allowing states to buy and import cheaper drugs from up north could be the answer to the nationâs drug-pricing problem.
By Shefali Luthra and Phil Galewitz -
Video: High Drama No Stranger At Congressional Health Care Hearings
Most hearings before the U.S. House and Senate are routine affairs. But a few tense moments featuring everyone from Hillary Clinton to tobacco CEOs drew the attention of millions of Americans.
By Julie Rovner and Mary Agnes Carey -
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you donât have to.
-
Talk About DĂŠjĂ Vu: Senators Set To Re-Enact Drug Price Hearing Of 60 Years Ago
Tuesdayâs Senate hearing with pharma CEOs will tackle the same issues as the famous Kefauver hearings in 1960.
By Jay Hancock -
Today’s Concerns About Drug Prices Echo The Past
Confrontational hearings 60 years ago sparked remarkably similar quotes about drug prices and health care policy.
-
More States Say Doctors Must Offer Overdose Reversal Drug Along With Opioids
In an emerging new tactic against the rising toll of opioid deaths, California, Ohio, Virginia and Arizona are among the states requiring physicians to offer patients naloxone when they give them prescriptions for the powerful painkillers. The Food and Drug Administration is weighing a national recommendation to do so.
-
The High Cost Of Sex: Insurers Often Donât Pay For Drugs To Treat Problems
Medicare and many private insurers view prescribing drugs to improve sexual function as a lifestyle issue thatâs not medically necessary to pay for.
-
Podcast: KHNâs âWhat The Health?â ‘Medicare-For-All’ For Dummies
The âMedicareâfor-allâ debate is already in full swing, but what does that phrase even mean? Joanne Kenen of Politico, Paige Winfield Cunningham of The Washington Post and Rebecca Adams of CQ Roll Call join KHNâs Julie Rovner for a beginnerâs guide to the next big health policy debate. For âextra credit,â the panelists provide their favorite health policy stories of the week, and as a special Valentineâs Day bonus, their favorite #HealthPolicyValentines.
-
Can California Beat The Federal Government In Lowering Drug Prices?
Unwilling to wait for federal action, California Gov. Gavin Newsom says he has a plan that could extract discounts from drugmakers and save the state money â one he hopes other states can join.
-
Americans Cross Border Into Mexico To Buy Insulin At A Fraction Of U.S. Cost
For one patient, a three-month supply of insulin is $3,700 in the U.S. versus $600 in Mexico. But is it legal?
-
False Lead: Senatorâs Offer To Help Patient Import Cheap Insulin Goes Nowhere
Sen. Mike Enzi said he knew of a foundation that would import insulin for patients, but it doesnât appear to exist.
By Jay Hancock -
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you donât have to.
-
What âDope Sickâ Really Feels Like
Just as each personâs journey into addiction is unique, different approaches work for people trying to find their way out. For me, detoxing was nightmarish. And a long-held dream come true.
By Brian Rinker -
Podcast: KHNâs âWhat The Health?â A âHealthyâ State Of The Union
Health was a featured player in President Donald Trumpâs 2019 State of the Union address. The president set goals to bring down prescription drug prices, end the HIV epidemic in the U.S. and cure childhood cancer, among other things. Margot Sanger-Katz of The New York Times, Anna Edney of Bloomberg News and Alice Ollstein of Politico join KHNâs Julie Rovner to discuss these issues and, for âextra credit,â provide their favorite health policy stories of the week. Rovner also interviews KHN senior correspondent Phil Galewitz about the current âBill of the Monthâ feature.
-
Trump Administration Salutes Parade Of Generic Drug Approvals, But Hundreds Arenât For Sale
President Donald Trump and FDA officials have pointed to a surge in generic drug approvals, but a data analysis indicates almost half havenât reached the market.
By Sydney Lupkin and Jay Hancock